ABSTRACT
No disponible
Subject(s)
Humans , Male , Aged, 80 and over , Mycobacterium bovis/isolation & purification , Administration, Intravesical , Aortitis/diagnostic imaging , Tuberculosis/diagnosis , Abdominal Pain/diagnostic imaging , Abdominal Pain/etiology , Aortitis/pathology , Microbial Sensitivity Tests/methods , Urinary Bladder NeoplasmsSubject(s)
Aortitis/diagnosis , BCG Vaccine/adverse effects , Mycobacterium bovis/isolation & purification , Tuberculosis/diagnosis , Administration, Intravesical , Aged, 80 and over , Aorta, Abdominal/diagnostic imaging , Aorta, Abdominal/microbiology , Aortitis/etiology , BCG Vaccine/administration & dosage , Echocardiography , Humans , Male , Tomography, X-Ray Computed , Tuberculosis/etiologySubject(s)
Telangiectasia, Hereditary Hemorrhagic/diagnostic imaging , Telangiectasia, Hereditary Hemorrhagic/surgery , Angiography , Arteriovenous Malformations/complications , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/surgery , Cyanosis/complications , Endovascular Procedures , Epistaxis/complications , Female , Humans , Pulmonary Artery/abnormalities , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/pathology , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Pulmonary Veins/pathology , Telangiectasia, Hereditary Hemorrhagic/complications , Tomography, X-Ray Computed , Young AdultABSTRACT
UNLABELLED: FUNDAMENTAL AND OBJECTIVE: To present the first experiences with a series of consecutive cases of patients with non-small cell lung cancer (NSCLC) treated with radiofrequency ablation (RFA), considering its clinical applicability, effectiveness and safety. PATIENTS AND METHODS: Descriptive study performed from June 2003 to March 2009, with a series of consecutive cases of patients with NSCLC treated with RFA, selected according to well-defined inclusion criteria, in different stages of the disease. The variables studied were local recurrence, complications, staging, demographic and procedure-related variables. Local control was assessed in posterior controls according to CT morphology criteria and/or lesion enhancement after intravenous contrast. Survival curves were estimated. Statistical analysis was performed with SPSS version 15.0 application. RESULTS: We studied 15 patients (46-88 years), diagnosed with NSCLC in different stages, in a total of 22 sessions. After 1 year of follow up, 75% of lesions showed no local recurrence (15). The progression-free survival and disease-free survival in localized stage at one year were 81,3% and 75% respectively. In 8 of 22 sessions there were post-procedure complications (36.36%). Of all complications (14), 28.5% were pneumothorax, 21.4% alveolar hemorrhage and 7.1% pulmonary infarction. CONCLUSION: ARF is clinically useful in the treatment of patients with inoperable NSCLC, considering the high percentage of local control and few major complications, being thus a plausible, effective and safe therapeutic alternative.
